Abstract

To elucidate the novel and common genetic changes in histopathologic subtype-specific profiles of renal cell carcinomas (RCCs), a newly developed high-resolution whole-genome array analysis was applied. Human CNV370-Duo DNA Analysis BeadChip (genotype 370K) was used in a panel of 22 primary clear cell RCCs (ccRCCs), seven papillary RCCs (PRCCs) (six type II and one type I) and eight chromophobe RCCs (ChRCCs). In ccRCC, a chromosome 3p loss was identified in 95% of the carcinomas, suggesting that 3p loss is the first stage in ccRCC carcinogenesis. Other frequent changes included losses of 1p (23%), 3q (46%) and 8p (32%), and gains of 5q (32%), 7p (27%), 7q (27%) and 1q (23%). The most frequent chromosomal losses in PRCC (43%) were noted in 3p and 3q, followed by 29% of losses of 1p, 1q, 11q, 18q, 22p and 22q, and gains of 20q (57%), 20p (43%), 8q (43%) and 12q (43%). Loss of the entire chromosomes 1, 2, 6, 8, 10, 13 or 17 was noted in patients with ChRCC. A high-density single nucleotide polymorphism array analysis confirmed that partial chromosomal changes rarely occur in ChRCC. Additionally, 32 microdeletions and 10 microamplifications of less than 1 Mb were detected, which may represent potential candidate tumor suppressor genes and oncogenes, respectively.

Highlights

  • Renal cell carcinomas (RCCs) constitute 2-3% of adult cancers and include clear cell RCC (75%), papillary RCC (PRCC) (10%) and chromophobe RCC (ChRCC) (5%)Key words: single nucleotide polymorphism array, comparative genomic hybridization, renal cell carcinoma subtypes [1,2]

  • Molecular-targeting drugs for advanced RCC were designed based on the von HippelLindau (VHL)-hypoxia inducible factor (HIF), vascular endothelial growth factor receptor (VEGFR), plateletderived growth factor (PDGF) and transforming growth factor transduction pathways [5], as well as the mammalian target of the rapamycin pathway [6]

  • The most common genetic loss in clear cell RCCs (ccRCCs) was identified in 3p, which was found in 95% (21/22 samples) of the carcinomas (Table I), suggesting that 3p loss is early stage in clear cell carcinogenesis

Read more

Summary

Introduction

Renal cell carcinomas (RCCs) constitute 2-3% of adult cancers and include clear cell RCC (ccRCC) (75%), papillary RCC (PRCC) (10%) and chromophobe RCC (ChRCC) (5%). Newly developed high-density single nucleotide polymorphism (SNP) array was applied to investigate novel and common genetic change in the three RCC subtypes

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.